ROBO1 and central nervous system cancer: An analysis of The Cancer Genome Atlas (TCGA) database demonstrated that ROBO1 expression was significantly elevated in glioma tissue in comparison with normal brain tissue, and patients with glioma expressing a high level of ROBO1 experienced significantly shorter survival (Fig. 3C, D).